Cargando…

A cost–benefit analysis of COVID-19 lockdowns in Australia

This paper conducts a cost–benefit analysis of Australia’s Covid-19 lockdown strategy relative to pursuit of a mitigation strategy in March 2020. The estimated additional deaths from a mitigation strategy are 11,500 to 40,000, implying a Cost per Quality Adjusted Life Year saved by locking down of a...

Descripción completa

Detalles Bibliográficos
Autor principal: Lally, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794621/
https://www.ncbi.nlm.nih.gov/pubmed/35088370
http://dx.doi.org/10.1007/s40592-021-00148-y
_version_ 1784640854329131008
author Lally, Martin
author_facet Lally, Martin
author_sort Lally, Martin
collection PubMed
description This paper conducts a cost–benefit analysis of Australia’s Covid-19 lockdown strategy relative to pursuit of a mitigation strategy in March 2020. The estimated additional deaths from a mitigation strategy are 11,500 to 40,000, implying a Cost per Quality Adjusted Life Year saved by locking down of at least 11 times the generally employed figure of $100,000 for health interventions in Australia. The lockdowns do not then seem to have been justified by reference to the standard benchmark. Consideration of the information available to the Australian government in March 2020 yields a similar ratio and therefore the same conclusion that lockdown was not warranted. If Australia experiences a new outbreak, and cannot contain it without resort to a nationwide lockdown, the death toll from adopting a mitigation strategy at this point would be even less than had it done so in March 2020, due to the vaccination campaign, lessons learned since March 2020, and because the period over which the virus would then inflict casualties would now be much less than the period from March 2020. This would favour a mitigation policy even more strongly than in March 2020. This approach of assessing the savings in quality adjusted life years and comparing them to a standard benchmark figure ensures that all quality adjusted life years saved by various health interventions are treated equally, which accords with the ethical principle of equity across people.
format Online
Article
Text
id pubmed-8794621
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-87946212022-01-28 A cost–benefit analysis of COVID-19 lockdowns in Australia Lally, Martin Monash Bioeth Rev Original Article This paper conducts a cost–benefit analysis of Australia’s Covid-19 lockdown strategy relative to pursuit of a mitigation strategy in March 2020. The estimated additional deaths from a mitigation strategy are 11,500 to 40,000, implying a Cost per Quality Adjusted Life Year saved by locking down of at least 11 times the generally employed figure of $100,000 for health interventions in Australia. The lockdowns do not then seem to have been justified by reference to the standard benchmark. Consideration of the information available to the Australian government in March 2020 yields a similar ratio and therefore the same conclusion that lockdown was not warranted. If Australia experiences a new outbreak, and cannot contain it without resort to a nationwide lockdown, the death toll from adopting a mitigation strategy at this point would be even less than had it done so in March 2020, due to the vaccination campaign, lessons learned since March 2020, and because the period over which the virus would then inflict casualties would now be much less than the period from March 2020. This would favour a mitigation policy even more strongly than in March 2020. This approach of assessing the savings in quality adjusted life years and comparing them to a standard benchmark figure ensures that all quality adjusted life years saved by various health interventions are treated equally, which accords with the ethical principle of equity across people. Springer International Publishing 2022-01-28 2022 /pmc/articles/PMC8794621/ /pubmed/35088370 http://dx.doi.org/10.1007/s40592-021-00148-y Text en © Monash University 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Lally, Martin
A cost–benefit analysis of COVID-19 lockdowns in Australia
title A cost–benefit analysis of COVID-19 lockdowns in Australia
title_full A cost–benefit analysis of COVID-19 lockdowns in Australia
title_fullStr A cost–benefit analysis of COVID-19 lockdowns in Australia
title_full_unstemmed A cost–benefit analysis of COVID-19 lockdowns in Australia
title_short A cost–benefit analysis of COVID-19 lockdowns in Australia
title_sort cost–benefit analysis of covid-19 lockdowns in australia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794621/
https://www.ncbi.nlm.nih.gov/pubmed/35088370
http://dx.doi.org/10.1007/s40592-021-00148-y
work_keys_str_mv AT lallymartin acostbenefitanalysisofcovid19lockdownsinaustralia
AT lallymartin costbenefitanalysisofcovid19lockdownsinaustralia